Investing Profile

Mohan S. Iyer

InvestorVC
General Partner at SOSV SF & NY (Formerly IndieBio)
sosv.com/team/mohan-s-iyerSan Francisco, California
Photo of Mohan S. Iyer, General Partner at SOSV SF & NY (Formerly IndieBio)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Duke University Network
235 CONNECTIONS
cb
$100K - $2.0M
$1M
29
CompanyStageDateRound SizeTotal Raised
Fermeate
SeedApr 2026$3M
$3M
Co-investors: Po Bronson (SOSV), Henri Deshays (NewFund)
Xtelligence
SeedApr 2026
Antarka Bio
SeedFeb 2026$4M
$4M
Endaris
SeedFeb 2026
Transition Metal Solutions
SeedJan 2026$6M
Pre SeedJul 2023
$6M
Co-investors: Po Bronson (SOSV), Christoph Baumeister (Possible Ventures)
DisperseBio
SeedJan 2026
SeedOct 2024
Cellens
SeedDec 2025$7M
$7M
Co-investors: Po Bronson (SOSV)
Finish Line Bio
SeedDec 2025
Co-investors: Po Bronson (SOSV)
Senior Process Engineer Genentech Inc.Present
Senior Healthcare Consultant Genentech Inc.Present
EVP, Corporate and Business Development Diazyme Laboratories, Inc.Present
Managing Director, Merchant Banking Genentech Inc.Present
CFO Tethys Bioscience, Inc.Present
Chief Business Officer Second Genome Inc.Present
COO Pendulum TherapeuticsPresent
General Partner SOSV SF & NY (Formerly IndieBio)Present
Duke University Graduate School Master of Science - MS Biomedical/Medical Engineering
University of Tennessee-Knoxville B.S. Chemical Engineering
University of Tennessee, Knoxville B.S. Chemical Engineering
Duke University MS Biomedical Engineering
Sign in with Google →
Sign in with Google →